Phase 1 Trial

Breaking Down Molly: Swiss University Studies How MDMA's Components Might Affect Humans

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity

eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity

eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study

Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients

Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial

Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients

Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial

Caribou's Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study

FDA Gives Green Signal To Human Trial For Sorrento's STI-9167 Against Omicron

Phase 1 Trial Recent News

Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine

AbbVie - Genmab Post Epcoritamab Data From Early-Stage Blood Cancer Study

Genmab A/S (NASDAQ: GMAB) and AbbVie Inc (NYSE: ABBV)

Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial

Cocrystal Pharma Inc (NASDAQ: COCP)

Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors

FDA Approves BioCardia's Phase 1 Trial With Cell Therapy In COVID-19, Shares Jump

IO Biotech Reveals Updated Data From IO102-IO103/Opdivo Combo Trial In Melanoma

IO Biotech Inc (NASDAQ: IOBT)

BioNTech Posts Interim Phase 1 Data From CAR-T/Cancer Vaccine Combo In Solid Tumors

BioNTech SE (NASDAQ: BNTX) presented data from its ongoing Phase 1/2 trial of its CAR-T cell therapy candidate, BNT211, in advanced solid tumors.

AIM ImmunoTech Shares Jump On Positive Data From Ampligen Study In Breast Cancer Setting

AIM ImmunoTech Inc (NYSE: AIM) has

Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL)

VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114

Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis

VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year

VBI Vaccines Inc (NASDAQ: VBIV) announced

Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model

Stealth BioTherapeutics Corp (NASDAQ: MITO) announced the presentation of

Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients

Portage Biotech Inc (NASDAQ: PRTG) has updated its clinical development programs and announced its development goals for 2022, and it continues to work toward multiple clinical readouts in 2022.

EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal

Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.

CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial

Synthetic Biologics' VCN-01 Shows Favorable Safety Profile, Clinical Activity In Early-Stage Cancer Study

Synthetic Biologics Inc (NYSE: SYN)

Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints

Biogen Inc (NASDAQ: BIIB) and Ionis Pharmaceuticals Inc (NASDAQ: IONS) have

Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients

Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate

Aligos Therapeutics Inc (NASDAQ: ALGS) has

Why ORIC Pharmaceuticals Shares Are Plunging Today

Terns Reports Topline Results from Early-Stage NASH Study

Terns Pharmaceuticals Inc (NASDAQ: TERN)

Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results